Anita Dushyanth
Stock Analyst at Berenberg
(2.72)
# 2,111
Out of 5,090 analysts
4
Total ratings
75%
Success rate
15.74%
Average return
Main Sectors:
Stocks Rated by Anita Dushyanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Initiates: Buy | $20 | $22.98 | -12.97% | 1 | Apr 27, 2022 | |
| SERA Sera Prognostics | Initiates: Buy | $13 | $3.08 | +322.08% | 1 | Apr 27, 2022 | |
| BTAI BioXcel Therapeutics | Initiates: Buy | $1,200 | $2.07 | +57,871.01% | 1 | Apr 9, 2021 | |
| PCRX Pacira BioSciences | Initiates: Buy | $93 | $23.99 | +287.66% | 1 | Apr 9, 2021 |
UroGen Pharma
Apr 27, 2022
Initiates: Buy
Price Target: $20
Current: $22.98
Upside: -12.97%
Sera Prognostics
Apr 27, 2022
Initiates: Buy
Price Target: $13
Current: $3.08
Upside: +322.08%
BioXcel Therapeutics
Apr 9, 2021
Initiates: Buy
Price Target: $1,200
Current: $2.07
Upside: +57,871.01%
Pacira BioSciences
Apr 9, 2021
Initiates: Buy
Price Target: $93
Current: $23.99
Upside: +287.66%